Taken together, the overexpression of OCT4 in bladder cancer confers resistance against cisplatin in vitro and in vivo, thus suggesting that the mechanism underlying acquired drug resistance may involve OCT4 overexpression [112]. This evidence concerns the gene POU5F1 and urinary bladder carcinoma.